Leonie Müller-Jensen

7PUBLICATIONS
34CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Immunogenetics (incl. genetic immunology)AutoimmunityNeurology and neuromuscular diseasesInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Oct 30, 2025
Clonally expanded effector CD4+ cytotoxic T lymphocytes are associated with severe neurological adverse events after immune checkpoint inhibitor therapy.

Ambre Manon Giguelay, Patrick Maschmeyer, Leonie Müller-Jensen

|Sep 23, 2025
HLA-A*01:01-B*08:01-C*07:01 is linked to early-onset immune checkpoint inhibitor-induced myositis and myocarditis.

Leonie Müller-Jensen, Lukas Flatz, Omar Hasan Ali

|Jun 12, 2025
Complement activation profiles in patients with immune checkpoint inhibitor-associated neuromuscular immune-related adverse events.

Leonie Müller-Jensen, Nora Möhn, Thomas Skripuletz

|Jan 29, 2025
Cognitive Deficits in Anti-LGI1 Encephalitis Are Linked to Immunotherapy-Resistant White Matter Network Changes.

Stephan Krohn, Leonie Müller-Jensen, Joseph Kuchling

|Oct 12, 2023
Immune signatures of checkpoint inhibitor-induced autoimmunity-A focus on neurotoxicity.

Leonie Müller-Jensen, Axel R Schulz, Henrik E Mei

Pageof 2